Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 605,191 shares of SLS stock, worth $665,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
605,191
Previous 517,008
17.06%
Holding current value
$665,710
Previous $615,000
22.93%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SLS
# of Institutions
39Shares Held
5.69MCall Options Held
1.67MPut Options Held
74.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.52 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX794KShares$873,2180.12% of portfolio
-
Black Rock Inc. New York, NY430KShares$473,4040.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$339,3123.71% of portfolio
-
Opus Capital Group, LLC226KShares$248,7100.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $22.6M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...